EnzyMark AI Lab Standard can signal tumor risk at around 1 million cells and supports early cancer pre-screening, 100+ disease risk signals, and 3-second post-surgery feedback, built on nearly 60,000 measurements, 60 years of clinical work, up to 98.6% sensitivitym, and 95% clinical agreement.
